Actualités ETF Series Solutions Trust Range Cancer Therapeutics - CNCR | Actions NASDAQ

Votre Hub pour des idées et discussions en direct en temps réel

EXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATION

EXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATION PR Newswire OKLAHOMA CITY, Oct. 23, 2023 OKLAHOMA CITY, Oct. 23, 2023...

Loncar China BioPharma ETF (CHNA) Launches on Nasdaq

CHNA offers diversified exposure to leading companies in China’s burgeoning BioPharma industry Today, the Loncar China BioPharma ETF...

Loncar Cancer Immunotherapy ETF (CNCR) Surpasses $50 Million in Assets Under Management

CNCR offers diversified exposure to 30 leading companies with immunotherapy focus The Loncar Cancer Immunotherapy ETF (Nasdaq: CNCR...

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Three Biotechnology Companies Added to the Index Loncar Investments, LLC today announced the result of the semi-annual rebalance and...

Loncar Cancer Immunotherapy Index Announces Merger Replacements

Gilead and NewLink Added to the Only Index that Tracks Cancer Immunotherapy Loncar Investments, LLC today announced two new additions to...

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Three Biotechnology Companies Added to the Index Loncar Investments, LLC today announced the result of the semi-annual rebalance and...

Cancer Immunotherapy ETF (Nasdaq: CNCR) to Ring the Nasdaq Stock Market Opening Bell

ADVISORY, Oct. 28, 2016 (GLOBE NEWSWIRE) -- What: Exchange Traded Concepts, Loncar Investments...

Cancer Immunotherapy ETF Celebrates One-Year Anniversary

Cancer immunotherapy companies are beneficially disrupting status quo cancer treatments by deploying body’s own immune system to fight...

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Two New Immunotherapy Companies Added to the Index Loncar Investments, LLC today announced the result of the semi-annual rebalance and...

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Investments, LLC today announced the result of the semi-annual rebalance and reconstitution of the Loncar Cancer Immunotherapy Index...

Loncar Investments Selects Cancer Research Institute as Exclusive Charitable Partner in Immunotherapy Research Donation Program

On Giving Tuesday, Loncar Investments and the Cancer Research Institute (CRI) announced that they have entered into an exclusive charitable...

Market’s Only Cancer Immunotherapy ETF Launches

Exchange Traded Concepts Partners with Loncar Investments, ISE ETF Ventures, and Amplify Development on the Loncar Cancer Immunotherapy ETF...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ETF Series Solutions Trust Range Cancer Therapeutics (CNCR)

Votre Hub pour des idées et discussions en direct en temps réel

CNCR Actualités

EXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATION

Loncar China BioPharma ETF (CHNA) Launches on Nasdaq

Loncar Cancer Immunotherapy ETF (CNCR) Surpasses $50 Million in Assets Under Management

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Cancer Immunotherapy Index Announces Merger Replacements

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Cancer Immunotherapy ETF (Nasdaq: CNCR) to Ring the Nasdaq Stock Market Opening Bell

Cancer Immunotherapy ETF Celebrates One-Year Anniversary

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Investments Selects Cancer Research Institute as Exclusive Charitable Partner in Immunotherapy Research Donation Program

Market’s Only Cancer Immunotherapy ETF Launches

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ETF Series Solutions Trust Range Cancer Therapeutics (CNCR) Actualités

ETF Series Solutions Trust Range Cancer Therapeutics (CNCR)

Votre Hub pour des idées et discussions en direct en temps réel

CNCR Actualités

EXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATION

Loncar China BioPharma ETF (CHNA) Launches on Nasdaq

Loncar Cancer Immunotherapy ETF (CNCR) Surpasses $50 Million in Assets Under Management

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Cancer Immunotherapy Index Announces Merger Replacements

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Cancer Immunotherapy ETF (Nasdaq: CNCR) to Ring the Nasdaq Stock Market Opening Bell

Cancer Immunotherapy ETF Celebrates One-Year Anniversary

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Investments Selects Cancer Research Institute as Exclusive Charitable Partner in Immunotherapy Research Donation Program

Market’s Only Cancer Immunotherapy ETF Launches

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application